These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1965705)

  • 1. The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors.
    Bakker GH; Setyono-Han B; Foekens JA; Portengen H; van Putten WL; de Jong FH; Lamberts SW; Reubi JC; Klijn JG
    Breast Cancer Res Treat; 1990 Nov; 17(1):23-32. PubMed ID: 1965705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
    Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
    Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical studies on the anticancer activity of the somatostatin analogue octreotide (SMS 201-995).
    Weckbecker G; Tolcsvai L; Liu R; Bruns C
    Metabolism; 1992 Sep; 41(9 Suppl 2):99-103. PubMed ID: 1325597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the luteinizing-hormone-releasing hormone (LHRH) antagonist ramorelix (hoe013) and the LHRH agonist buserelin on dimethylbenz[]anthracene-induced mammary carcinoma: studies with slow-release formulations.
    Stoeckemann K; Sandow J
    J Cancer Res Clin Oncol; 1993; 119(8):457-62. PubMed ID: 8509436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
    Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
    Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies on the anticancer activity of the somatostatin analog octreotide (SMS 201-995).
    Weckbecker G; Tolcsvai L; Liu R; Bruns C
    Digestion; 1993; 54 Suppl 1():98-103. PubMed ID: 8359575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of lutenizing hormone-releasing hormone analogue with antiestrogen on rat mammary tumors.
    Matsumoto H; Koibuchi Y; Horiguchi J; Iino Y; Morishita Y
    Oncol Rep; 2002; 9(1):145-51. PubMed ID: 11748473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of 1 alpha,25-dihydroxyvitamin D3 on the development and steroid hormone receptor contents of DMBA-induced rat mammary tumors.
    Noguchi S; Tahara H; Miyauchi K; Koyama H
    Oncology; 1989; 46(4):273-6. PubMed ID: 2500626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibitory activity of a new antiestrogen, RU 16 117, on the development and growth of DMBA-induced rat mammary adenocarcinoma.
    Labrie F; Kelly PA; Asselin J; Raynaud JP
    Recent Results Cancer Res; 1976; (57):109-20. PubMed ID: 827798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an LHRH analog on growth and hormone receptor levels in DMBA-induced mammary tumors in the rat.
    Turcot-Lemay L; Cusan L; Séquin C; Kelly P; Labrie F
    J Recept Res; 1981; 2(2):135-51. PubMed ID: 6271961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone.
    Reissmann T; Hilgard P; Harleman JH; Engel J; Comaru-Schally AM; Schally AV
    J Cancer Res Clin Oncol; 1992; 118(1):44-9. PubMed ID: 1530849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
    Yamamoto H; Morimoto T; Monden A
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrone on the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in the rat: a model of postmenopausal breast cancer.
    Li S; Martel C; Dauvois S; Bélanger A; Labrie F
    Endocrinology; 1994 Mar; 134(3):1352-7. PubMed ID: 8119175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S; Stojanovic M; Labrie C; Labrie F
    Int J Cancer; 1997 Nov; 73(4):580-6. PubMed ID: 9389575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-receptor pathway interfering treatment by somatostatin analogs and suramin: preclinical and clinical studies.
    Klijn JG; Setyono-Han B; Bakker GH; van der Burg ME; Bontenbal M; Peters HA; Sieuwerts AM; Berns PM; Foekens JA
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1089-95. PubMed ID: 1981013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Zaccheo T; Giudici D; Lombardi P; di Salle E
    Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.